|
|
||||||||
Papers In Press, published online ahead of print April 16, 2003
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
University of Ottawa Heart Institute, Ottawa, Ontario K1Y 4W7
Corresponding Author: dsparks{at}ottawaheart.ca
Administration of phosphatidylinositol (PI) into NZW rabbits increases HDL negative charge and stimulates reverse cholesterol transport. Intravenously administered PI (10 mg/kg) associated almost exclusively with the HDL fraction in rabbits. PI promoted an increase in the hepatic uptake of plasma free cholesterol and a 21-fold increase in the biliary secretion of plasma derived cholesterol. PI also increased cholesterol excretion into the feces by 2.5-fold. PI directly affects cellular cholesterol metabolism. In cholesterol loaded macrophages, PI stimulated cholesterol mass efflux to lipid-poor reconstituted HDL. PI was about half as effective as cAMP at stimulating efflux and the effects of cAMP and PI were additive. In cultured HepG2 cells, PI-enriched HDL also enhanced free cholesterol uptake from HDL by 3-fold and decreased cellular cholesterol synthesis and esterification. PI-enrichment had no effect on the selective uptake of cholesterol esters or on the internalization of HDL particles. PI-dependent metabolic events were efficiently blocked by inhibitors of protein kinase C and the inositol signaling cascade. The data suggests that HDL-PI acts via cell surface ABC transporters and signaling pathways to regulate both cellular and intravascular cholesterol homeostasis.
Revised on March 20, 2003
Accepted on April 14, 2003
Phosphatidylinositol promotes cholesterol transport and excretion
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:
![]() |
D. Duffy and D. J. Rader Emerging Therapies Targeting High-Density Lipoprotein Metabolism and Reverse Cholesterol Transport Circulation, February 28, 2006; 113(8): 1140 - 1150. [Full Text] [PDF] |
||||
![]() |
J. W. Burgess, T. A-M. Neville, P. Rouillard, Z. Harder, D. S. Beanlands, and D. L. Sparks Phosphatidylinositol increases HDL-C levels in humans J. Lipid Res., February 1, 2005; 46(2): 350 - 355. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
| All ASBMB Journals | Journal of Biological Chemistry |
| Molecular and Cellular Proteomics | ASBMB Today |